Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,395,610
+$1,395,610 QoQ
Shares Held
3,854
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,477
of 3,140 holders
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Jun 30, 2026CallValue
$5,069,680
CallShares
14,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lighthouse Investment Partners, LLC holds $17,722,466 across 7 Drug Manufacturers - General names. AMGN ranks #7 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,975 | $4,057,170 | |
| 2 | LLY |
ELI LILLY & Co
|
2,857 | $3,426,771 | |
| 3 | NVO |
Novo Nordisk A S
|
67,554 | $3,238,538 | |
| 4 | ABBV |
AbbVie Inc.
|
10,270 | $2,584,342 | |
| 5 | BIIB |
Biogen Inc.
|
7,500 | $1,620,450 | |
| 6 | AZN |
Astrazeneca PLC
|
7,381 | $1,399,585 | |
| 7 | AMGN |
Amgen Inc
This page
|
3,854 | $1,395,610 |
All Filings in AMGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,069,680 | 14,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $1,395,610 | 3,854 | Shares | Defined | 2026-08-14 | |
| 2024-12-31 | $2,606,400 | 10,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $1,933,260 | 6,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,155,074 | 48,504 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||